REMEDY.HEREMEDY.HEHEL

Revenue (LTM)

$60M

+17.5% YoY

Net Income (LTM)

$-13M

-262.3% YoY

Free Cash Flow

$5M

Revenue CAGR (5Y)

+7.7%

Marginsdeclining

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	45	44↓2.5%	34↓22.2%	51↑49.3%	60↑17.5%
Gross Profit	53	32↓40.1%	17↓46.3%	34↑99.5%	-4↓111.2%
Operating Income	11	-1↓105.1%	-29↓4810.3%	-4↑85.0%	-15↓247.3%
Net Income	9	-2↓119.6%	-23↓1212.7%	-4↑84.1%	-13↓262.3%
EBITDA	15	1↓90.0%	-24↓1771.9%	3↑111.5%	11↑304.1%
EPS Diluted	0.64	-0.13↓120.3%	-1.68↓1192.3%	-0.27↑83.9%	-0.96↓255.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	51	49↓4.6%	20↓59.1%	21↑4.6%	10↓54.1%
Total Current Assets	78	68↓12.5%	44↓34.9%	47↑6.7%	45↓5.4%
Total Assets	100	100↓0.3%	79↓20.4%	99↑25.3%	88↓11.9%
Total Current Liabilities	12	10↓13.7%	10↑0.3%	16↑62.2%	14↓15.6%
Total Liabilities	13	11↓11.0%	12↑2.8%	31↑167.6%	31↑0.5%
Total Equity	87	88↑1.2%	68↓23.3%	69↑1.1%	57↓17.4%
Total Debt	4	3↓22.4%	4↑22.3%	16↑332.6%	18↑15.4%
Net Debt	-49	-46↑5.3%	-16↑64.4%	-5↑68.5%	9↑267.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	12	5↓56.1%	11↑113.6%	-16↓244.9%	12↑176.5%
Capital Expenditure	-6	-13↓98.6%	-11↑15.4%	-2↑78.6%	-7↓197.9%
Free Cash Flow	5	-7↓235.9%	0↑105.6%	-18↓4546.1%	5↑129.8%
Stock-Based Comp	0	2	4↑46.6%	3↓25.5%	2↓10.9%
Net Change in Cash	4	28↑569.0%	-2↓108.5%	-29↓1132.7%	1↑103.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance